How to recognize PCOS: results of a web-based survey at IVF-worldwide.com
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
This retrospective evaluation of a web-based survey posted from 1 to 30 September 2010 was to determine which diagnostic tools physicians are currently utilizing to diagnose polycystic ovary syndrome (PCOS). Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82%), National Institutes of Health criteria (8%), Androgen Excess Society 2006 criteria (3%) and other classification systems (7%). Many providers utilized diagnostic tools not necessarily included in traditional classification systems: 58% of respondents evaluated LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-Müllerian hormone (22%) and impaired glucose tolerance (74%) in diagnosing PCOS. Many respondents (64%) felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In conclusion, while the majority of centres (82%) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future. Polycystic ovary syndrome (PCOS) is a common endocrine disorder with a heterogeneous constellation of clinical manifestations which primarily affects reproductive-aged women. This clinical heterogeneity has resulted in a challenging path to create universally accepted diagnostic criteria for PCOS. To determine which diagnostic tools physicians are currently utilizing to diagnose PCOS, we evaluated a web-based survey posted on IVF-Worldwide.com from 1 to 30 September 2010. Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82%), National Institutes of Health criteria (8%), Androgen Excess Society 2006 criteria (3%) and another classification system (7%). Many providers utilized diagnostic tools not necessarily included in these traditional classification systems: 58% of respondents evaluated the LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-Müllerian hormone (22%) and impaired glucose tolerance (74%) in diagnosing PCOS; and 64% of all respondents felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In summary, while the majority of centres (82%) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 1×
“A strong correlation exists between PCOS and metabolic syndrome (Baranova et al., 2011; Moran et al., 2010; Rahmanpour et al., 2012; Teede et al., 2010).”
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1×
“A strong correlation exists between PCOS and metabolic syndrome (Baranova et al., 2011; Moran et al., 2010; Rahmanpour et al., 2012; Teede et al., 2010).”
BackgroundThe role of lifestyle modification in polycystic ovary syndrome
Norman, R. J., Davies, M. J., Lord, J., & Moran, L. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00612-4 · Cited by 326 · cited 1×
“Polycystic ovary syndrome (PCOS) is a common endocrine disorder with a heterogeneous constellation of clinical manifestations which primarily affects reproductive-aged women (Norman et al., 2002).”
BackgroundPanidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155 · cited 1×
“Consequently, some have promoted evaluating patients for the presence of insulin resistance when PCOS is suspected (Baptiste et al., 2010; Panidis et al., 2012; Wongwananuruk et al., 2012).”
Background
Cited by
Polycystic ovary syndrome throughout a woman’s life
Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180
Gibson-Helm, M., Dokras, A., Karro, H., Piltonen, T., & Teede, H. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667155 · Cited by 56
Tassone, E., Teede, H., Dokras, A., Garad, R., & Gibson-Helm, M. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1668086 · Cited by 48
Tay, C. T., Williams, F., Mousa, A., Teede, H., & Burgert, T. S. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777086 · Cited by 8
“39 A more recent survey of physicians from North America found that 68% of reproductive endocrinologists and less than half (41”
BackgroundUnraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Metadata
- Authors
- Ning, N., Balen, A., Brezina, P. R., Leong, M., Shoham, Z., Wallach, E. E., & Zhao, Y.
- Venue
- Reproductive BioMedicine Online
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 26
- Issue
- 5
- Pages
- 500-505
- ISSN
- 1472-6483 (ISSN-L)
- OpenAlex
- W2008881605
- Cited by
- 18
- References
- 8
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How to recognize PCOS: results of a web-based survey at IVF-worldwide.com. https://app.cochat.ai/papers/10.1016/j.rbmo.2013.01.009
- The paper
- Ning, N., Balen, A., Brezina, P. R., Leong, M., Shoham, Z., Wallach, E. E., & Zhao, Y. (2013). How to recognize PCOS: results of a web-based survey at IVF-worldwide.com. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2013.01.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.